Nanosonics has secured a second US FDA 510(k) clearance for its CORIS System, expanding the range of colonoscopes and gastroscopes eligible for reprocessing. The regulatory milestone supports planned US launch activities, although the company has not disclosed a launch date or financial forecast.
Nanosonics Limited reported a 9% revenue increase in the first half of FY26, driven by a growing installed base and recurring sales, while advancing the commercial rollout of its new CORIS endoscope reprocessing system.